Aselle Adaim

Aselle Adaim has held various leadership roles in clinical research and operations within the pharmaceutical industry. Currently serving as Head of Regional Study Management, Feasibilities, Site Engagement ANZ at BeiGene, Aselle previously led global clinical programs at Merck Group for Cetuximab and Avelumab. With a background in managing clinical affairs and overseeing early-phase programs in the Asia-Pacific region at Sirtex Medical Limited, Aselle's experience includes strategic planning, vendor management, and clinical trial oversight. Through roles at Novo Nordisk and various research institutions, Aselle has demonstrated a strong commitment to advancing oncology trials and developing successful clinical operations teams.